Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prevest Denpro's EBIT per Share for the
three
months ended in Jun. 2026 was ₹6.30.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹24.31.
During the past 12 months, the average EBIT per Share Growth Rate of Prevest Denpro was 15.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 6.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 13.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Prevest Denpro's EBIT per Share or its related term are showing as below:
BOM:543363'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 6.3 Med: 17.3 Max: 46.1
Current: 6.3
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of Prevest Denpro was 46.10% per year. The lowest was 6.30% per year. And the median was 17.30% per year.
BOM:543363's 3-Year EBIT Growth Rate is ranked worse than 54.76% of 683
companies
in the Medical Devices & Instruments industry
Industry Median: 9.8
vs BOM:543363: 6.30
Prevest Denpro's EBIT for the
three
months ended in Jun. 2026 was ₹75.6 Mil.
Prevest Denpro (BOM:543363) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Prevest Denpro EBIT per Share Related Terms
Prevest Denpro EBIT per Share Historical Data
* Premium members only.
The historical data trend for Prevest Denpro's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹24.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prevest Denpro (BOM:543363) has a EBIT per Share of ₹24.31 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Prevest Denpro and its competitors. According to the industry distribution chart, Prevest Denpro ranks #374 out of 683 companies in the Medical Devices & Instruments industry, placing it in the top 54.8%.
Is Prevest Denpro's EBIT per Share too high?
Prevest Denpro's current EBIT per Share is ₹24.31. Based on the distribution chart, Prevest Denpro ranks #374 out of 683 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Prevest Denpro has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Prevest Denpro's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prevest Denpro ranks #374 out of 683 companies for EBIT per Share. This places Prevest Denpro in the lower half of its industry. The industry median EBIT per Share is 9.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.80, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Prevest Denpro and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prevest Denpro's current EBIT per Share is ₹24.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prevest Denpro stock overvalued right now?
Based on GuruFocus' analysis, Prevest Denpro (BOM:543363) is currently considered Possible Value Trap. The stock's GF Value™ is ₹613.45, compared to a current price of ₹377.20 — trading 38.5% below its estimated fair value. The current EBIT per Share is ₹24.31. Prevest Denpro's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Prevest Denpro (BOM:543363), the current EBIT per Share is ₹24.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prevest Denpro (BOM:543363) Overvalued in 2026?
Based on GuruFocus' analysis, Prevest Denpro stock appears to be undervalued.
The current stock price of ₹377.20 is trading 38.5% below its estimated GF Value™ of ₹613.45.
GuruFocus considers Prevest Denpro to be Possible Value Trap.
Key valuation signals for BOM:543363:
EBIT per Share: ₹24.31
GF Value™: ₹613.45 vs. price of ₹377.20 (38.5% below fair value)
No single metric tells the full story. See the BOM:543363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prevest Denpro Ltd is an Indian manufacturer of dental materials and consumables, based in Jammu. The company develops, produces, and markets a broad portfolio spanning preventive, restorative, endodontic, orthodontic, and aesthetic dentistry. Its products include clinical dental materials such as composites, cements, and bonding agents, along with laboratory products, 3D printing dental resins, oral-care items, and hygiene and disinfection solutions. Prevest Denpro serves dental professionals, clinics, laboratories, and distributors, selling under its own brands rather than as a contract manufacturer. It generates revenue primarily through product sales, with a significant portion derived from exports to international markets across Europe, Asia, Africa, and the Middle East, alongside domestic sales in India. The company operates its own manufacturing facilities and emphasizes in-house research and development to expand its catalog of dental consumables.
86GF Score
Get the complete analysis for BOM:543363
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543363 has been successfully added to your 
